As used in this chapter of the Administrative Code:
(A) "Compounded sterile product prescription" shall have the same meaning as in rule 4729-19-01 of the Administrative Code.
(B) "Fluid therapy pharmacy" means a pharmacy where the primary purpose is to compound and dispense parenteral compounded sterile product prescriptions. Such a pharmacy must comply with the minimum standards for compounding parenteral or sterile product prescriptions as defined in rule 4729-19-04 of the Administrative Code.
Replaces: Replaces 4729-31-01
Effective: 01/01/2009
R.C.
119.032 review dates: 12/01/2013
Promulgated Under:
119.03
Statutory
Authority:
3719.28,
4729.26
Rule
Amplifies:
3719.01,
4729.01
Prior
Effective Dates: 3/1/1999